search again

Nationwide rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $416,869 · 10th–90th $4,898–$426,5800%50%10th90th$416,869Professionalmedian $416,869 · 10th–90th $68–$446,6840%50%10th90th$416,869$0.5$5.0$50.0$500.0$5.0K$50.0K$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $512,861.38
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $616,595.00

See more rates by state

Want provider-level rates data? We offer custom data extracts for a reasonable fee. To learn more, please email us.